Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
33 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Vanda Pharmaceuticals Inc. (Vanda Pharmaceuticals) is a bio-pharmaceutical company that develops and commercializes pharmaceutical products for treating central nervous system disorders. The company provides Hetlioz (tasimelteon) for the treatment of non-24-hour sleep-wake disorder in the US, and filed MAA for the product in Europe. It also offers Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults.

Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detai

  
Source:
Document ID
GDPH140528D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Vanda Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deal Details1020
  Licensing Agreements101
    Vanda Pharma Terminates Licensing Agreement with Novartis for Fanapt102
    Novartis Pharma Enters into Licensing Agreement with Vanda Pharma for AQW-051122
    Vanda Pharma Enters Into Licensing Agreement With Eli Lilly For VLY-686142
    Vanda Pharma Enters Into Licensing Agreement With MegaPharm For Fanapt162
    Vanda Pharma Enters Into Licensing Agreement With Biotoscana Farma For Fanapt182
    Vanda Pharma Enters Into Licensing Agreement With Probiomed For Fanapt202
    Vanda Pharma Amends Licensing Agreement With Bristol-Myers Squibb222
  Equity Offering241
    Vanda Pharma Raises USD25 Million in Private Placement of Common Stock242
    Vanda Pharma Raises USD66.7 Million in Public Offering of Shares262
    Vanda Pharma Completes Public Offering Of Shares For US$52 Million282
Vanda Pharmaceuticals Inc. - Key Competitors301
Key Employees311
Locations And Subsidiaries321
  Head Office321
  Other Locations &Subsidiaries321
Appendix331
  Methodology331
  About GlobalData331
  Contact Us331
  Disclaimer331

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vanda-Pharmaceuticals-Inc-VNDA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10410>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Vanda Pharmaceuticals Inc. (VNDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vanda-Pharmaceuticals-Inc-VNDA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10410>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research